Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein

Marc C Johnson1, Terri D Lyddon2, Reinier Suarez2

  • 1Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Christopher S. Bond Life Sciences Center, Columbia, Missouri, USA marcjohnson@missouri.edu.

Journal of Virology
|August 14, 2020
PubMed
Summary

Researchers optimized severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) Spike pseudotyped viruses for enhanced infectivity. These pseudotyped viruses are effective tools for detecting neutralizing antibodies against SARS-COV-2 in COVID-19 patient plasma.